Pertuzumab (Perjeta)
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Pertuzumab (Perjeta), covering 2016-06-06 to 2025-09-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + Trastuzumab [Phase 3]